Hofon Capital
华方资本
elsewhere's corpus does not cover Hofon Capital as a subject. The only mentions in the bundle are as a co-lead investor in Qiongding Medical's round in March 2025 and a follow-on investor in Chemical.AI's Series A+ in 2021 — both in articles published by other institutions (峰瑞资本 and 源码资本 respectively), not as profile material about Hofon itself. No founding date, team, strategy, or fund size is provided.
AI-generated — may contain errors, please verify.
Coverage
7 Interdisciplinary Companies Close New Funding Rounds | FreeS Family Funding News Vol.22
Looking forward to working alongside more outstanding founders.
High-end networking chip company **Zhuanxin** has completed its Series A2 funding round, targeting the AI computing network market.
Meeting the high-bandwidth networking demands of AI computing clusters.
Biotech Firms Raise Nearly 4 Billion Yuan, Consumer Companies Land Over 1.4 Billion | FreeS Family Funding Roundup · August
We've also released three short videos this week — follow us to check them out.
Chemical.AI, an intelligent chemical synthesis platform, announced the completion of a nearly $15 million Series A+ funding round led by Source Code Capital.
Dedicated to solving new drug synthesis problems through artificial intelligence and chemical big data
